{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:17:31Z","timestamp":1785309451310,"version":"3.55.0"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The aim of our study is to review the current available knowledge regarding preferences and expectations of patients with overactive bladder (OAB). The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement guidelines were followed for this manuscript\u2019s preparation. Three online databases were searched: PubMed\/Medline, Embase, and Scopus, while a combination of the following keywords was used: detrusor overactivity, overactive bladder, urinary incontinence, perspectives, expectations, and preferences. Overall, 1349 studies were retrieved and screened while only 10 studies appeared to be relevant for the scope of this review. Most of the studies were related to preferences about OAB medications (i.e., antimuscarinics); four of them reported patients\u2019 inclinations to alternative treatments in the case of medication therapy failure (i.e., neuromodulation, Botox). No data were found about diagnosis or other aspects of disease management (i.e., surgery, follow-up). Based on these findings, from the patient\u2019s point of view, the ideal medication should be cheap, without risk of cognitive function impairment, and able to reduce daytime urinary frequency and incontinence episodes.<\/jats:p>","DOI":"10.3390\/jcm12020396","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T02:54:55Z","timestamp":1672800895000},"page":"396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patients\u2019 Preferences and Expectations in Overactive Bladder: A Systematic Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2889-5259","authenticated-orcid":false,"given":"Antonio","family":"Cicione","sequence":"first","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lombardo","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Umbaca","sequence":"additional","affiliation":[{"name":"Urologia, ASP Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Tema","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"},{"name":"Unit of Urology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-3401","authenticated-orcid":false,"given":"Giacomo","family":"Gallo","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1194-1634","authenticated-orcid":false,"given":"Jordi","family":"Stira","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gravina","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Turchi","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Franco","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mancini","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nacchia","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Damiano","sequence":"additional","affiliation":[{"name":"Unit of Urology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tubaro","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-512X","authenticated-orcid":false,"given":"Cosimo","family":"De Nunzio","sequence":"additional","affiliation":[{"name":"Urology Unit, Ospedale Sant\u2019Andrea, \u2018Sapienza\u2019 University of Rome, 00191 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int. Urogynecol. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1464-410X.2009.09036.x","article-title":"Patient-Reported Reasons for Discontinuing Overactive Bladder Medication","volume":"105","author":"Benner","year":"2010","journal-title":"BJU Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1742-1241.2010.02626.x","article-title":"Persistence and Adherence in the Treatment of Overactive Bladder Syndrome with Anticholinergic Therapy: A Systematic Review of the Literature","volume":"65","author":"Sexton","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to Improve Medication Adherence: A Review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sahakyan, Y., Erman, A., Bhojani, N., Chughtai, B., Zorn, K.C., Sander, B., and Elterman, D.S. (2022). Pharmacotherapy vs. Minimally Invasive Therapies as Initial Therapy for Moderate-to-Severe Benign Prostatic Hyperplasia: A Cost-Effectiveness Study. Prostate Cancer Prostatic Dis., 1\u20136. Available online: https:\/\/www.nature.com\/articles\/s41391-022-00561-2.","DOI":"10.1038\/s41391-022-00561-2"},{"key":"ref_6","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D., Peterson, J., and Welch, V. (2011). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis, Ottawa Hospital Research Institute."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/01.ju.0000140957.31325.7f","article-title":"Eliciting Preferences for Drug Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia","volume":"172","author":"Watson","year":"2004","journal-title":"J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/SPV.0b013e318223c8ad","article-title":"Patient Preferences for Different Severities of and Treatments for Overactive Bladder","volume":"17","author":"Wu","year":"2011","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00345-011-0756-2","article-title":"Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"30","author":"Fourcade","year":"2012","journal-title":"World J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/nau.24618","article-title":"Patient Preference Elicitation Instrument, OABCare, to Facilitate Shared Decision-Making in the Care of Overactive Bladder","volume":"40","author":"Chhatre","year":"2021","journal-title":"Neurourol. Urodyn."},{"key":"ref_11","first-page":"55","article-title":"Using Discrete Choice Experiments to Value Health Care Programmes: Current Practice and Future Research Reflections","volume":"2","author":"Ryan","year":"2003","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhealeco.2003.09.003","article-title":"Valuing Health Care Using Willingness to Pay: A Comparison of the Payment Card and Dichotomous Choice Methods","volume":"23","author":"Ryan","year":"2004","journal-title":"J. Health Econ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2147\/PPA.S177540","article-title":"A Systematic Review of Questionnaires about Patient\u2019s Values and Preferences in Clinical Practice Guidelines","volume":"12","author":"Bai","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2147\/PPA.S178668","article-title":"A Patient-Reported, Non-Interventional, Cross-Sectional Discrete Choice Experiment to Determine Treatment Attribute Preferences in Treatment-Na\u00efve Overactive Bladder Patients in the US","volume":"12","author":"Athavale","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1185\/03007995.2016.1142959","article-title":"Patient and Physician Preferences for Oral Pharmacotherapy for Overactive Bladder: Two Discrete Choice Experiments","volume":"32","author":"Heisen","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1464-410X.2010.09882.x","article-title":"Preferences for Antimuscarinic Therapy for Overactive Bladder","volume":"108","author":"Swinburn","year":"2011","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40266-017-0474-6","article-title":"Older People\u2019s Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment","volume":"34","author":"Decalf","year":"2017","journal-title":"Drugs Aging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.juro.2007.08.006","article-title":"The Relative Importance of Health Related Quality of Life and Prescription Insurance Coverage in the Decision to Pharmacologically Manage Symptoms of Overactive Bladder","volume":"178","author":"Harpe","year":"2007","journal-title":"J. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11255-015-1100-3","article-title":"Patient Preferences for Treating Refractory Overactive Bladder in the UK","volume":"47","author":"Hashim","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sc.2010.65","article-title":"Patient Preferences for Next Generation Neural Prostheses to Restore Bladder Function","volume":"49","author":"Sanders","year":"2011","journal-title":"Spinal Cord"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/UA.UA_172_16","article-title":"Patient Treatment Preferences for Symptomatic Refractory Urodynamic Idiopathic Detrusor Overactivity","volume":"9","author":"Fontaine","year":"2017","journal-title":"Urol. Ann."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17562872211041470","DOI":"10.1177\/17562872211041470","article-title":"Real-Life Patient Experiences of TTNS in the Treatment of Overactive Bladder Syndrome","volume":"13","author":"Janssen","year":"2021","journal-title":"Ther. Adv. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","article-title":"What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women","volume":"65","author":"Agarwal","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.archger.2016.11.006","article-title":"Adverse Events and Treatment Discontinuations of Antimuscarinics for the Treatment of Overactive Bladder in Older Adults: A Systematic Review and Meta-Analysis","volume":"69","author":"Vouri","year":"2017","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"De Nunzio, C., Presicce, F., Lombardo, R., Trucchi, A., Bellangino, M., Tubaro, A., and Moja, E. (2018). Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: A key point to improve patients\u2019 care\u2014A systematic review. BMC Urol., 18.","DOI":"10.1186\/s12894-018-0376-x"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2174\/1389450116666150806124345","article-title":"The current indications and the benefits of combining a \u03b23-agonist with an anticholinergic for the treatment of OAB","volume":"16","author":"Presicce","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_27","first-page":"831","article-title":"Night Shift Workers Refer Higher Urinary Symptoms with an Impairment Quality of Life: A Single Cohort Study","volume":"73","author":"Nacchia","year":"2021","journal-title":"Minerva Urol. Nefrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.eururo.2020.12.032","article-title":"Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men","volume":"79","author":"Brucker","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.clgc.2019.07.002","article-title":"Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index","volume":"17","author":"Cicione","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chesnut, G.T., Tin, A.L., Fleshner, K.A., Benfante, N.E., Vickers, A.J., Eastham, J.A., Sjoberg, D.D., and Carlsson, S.V. (2021). Estimating Patient Health in Prostate Cancer Treatment Counseling. Prostate Cancer Prostatic Dis., Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/34732855\/.","DOI":"10.1038\/s41391-021-00467-5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","article-title":"A Systematic Review of Patients\u2019 Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms","volume":"79","author":"Malde","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ornaghi, P.I., Porreca, A., Sandri, M., Sciarra, A., Falsaperla, M., Ludovico, G.M., Cerruto, M.A., and Antonelli, A. (2022). Features of Patients Referring to the Outpatient Office Due to Benign Prostatic Hyperplasia: Analysis of a National Prospective Cohort of 5815 Cases. Prostate Cancer Prostatic Dis., 1\u20136. Available online: https:\/\/www.nature.com\/articles\/s41391-022-00575-w.","DOI":"10.1038\/s41391-022-00575-w"},{"key":"ref_33","unstructured":"Huang, J., Chan, C.-K., Yee, S., Deng, Y., Bai, Y., Chan, S.C., Tin, M.S., Liu, X., Lok, V., and Zhang, L. (2022). Global Burden and Temporal Trends of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis. Prostate Cancer Prostatic Dis., 1\u20138. Available online: https:\/\/www.nature.com\/articles\/s41391-022-00610-w."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41391-021-00435-z","article-title":"Poor Clinical Guideline Adherence and Inappropriate Testing for Incident Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia","volume":"25","author":"Welliver","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:58:09Z","timestamp":1760119089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12020396"],"URL":"https:\/\/doi.org\/10.3390\/jcm12020396","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}